AKRO - Akero Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

AKRO is currently covered by 9 analysts with an average price target of $42.26. This is a potential upside of $18.05 (74.56%) from yesterday's end of day stock price of $24.21.

Akero Therapeutics's activity chart (see below) currently has 15 price targets and 36 ratings on display. The stock rating distribution of AKRO is 92.31% BUY and 7.69% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.19% with an average time for these price targets to be met of 190.33 days.

Highest price target for AKRO is $60, Lowest price target is $33, average price target is $42.26.

Most recent stock forecast was given by ED ARCE from HCWAINWRIGHT on 14-Nov-2023. First documented stock forecast 15-Jul-2019.

Currently out of the existing stock ratings of AKRO, 24 are a BUY (92.31%), 2 are a HOLD (7.69%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

40

$15.79 (65.22%)

40

3 months 12 days ago

0/7 (0%)

$25.09 (168.28%)

Buy

39

$14.79 (61.09%)

83

4 months 14 days ago

0/2 (0%)

$24.31 (165.49%)

Buy

33

$8.79 (36.31%)

70

4 months 15 days ago

1/5 (20%)

$17.96 (119.41%)

329

Buy

41

$16.79 (69.35%)

62

4 months 15 days ago

2/4 (50%)

$25.96 (172.61%)

433

Buy

39

$14.79 (61.09%)

69

4 months 15 days ago

0/3 (0%)

$23.96 (159.31%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AKRO (Akero Therapeutics) average time for price targets to be met?

On average it took 190.33 days on average for the stock forecasts to be realized with a an average price target met ratio 40.19

Which analyst has the current highest performing score on AKRO (Akero Therapeutics) with a proven track record?

EDWARD NASH

Which analyst has the current lower performing score on AKRO (Akero Therapeutics) with a proven track record?

ELIANA MERLE

Which analyst has the most public recommendations on AKRO (Akero Therapeutics)?

Edward Nash works at CANACCORD and has 5 price targets and 3 ratings on AKRO

Which analyst is the currently most bullish on AKRO (Akero Therapeutics)?

Liisa Bayko with highest potential upside - $35.79

Which analyst is the currently most reserved on AKRO (Akero Therapeutics)?

Michael Ulz with lowest potential downside - $8.79

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?